|
A new impotence drug, the world's fifth, has been developed by a Korean company and approved for sale in Korea.
SK Chemicals said on Thursday that its impotence drug MVIX was approved by the Korea Food & Drug Administration and will go on sale from the middle of next month.
MVIX is the 13th new drug developed by the Korean company. SK Chemicals has spent W15 billion (US$1=W915) on creating the drug in partnership with bio venture firm IN2GEN.
MVIX is the world's fifth impotence drug after Viagra, Cialis, and Levitra by multinational pharmaceutical companies and Zydena by Korean drug maker Dong-A Pharm.
With Korean drug company Chong Kun Dang Pharmaceutical selling Bayer's Levitra under the name Yaila, Korea's impotence drug market is expected to see competition between five drugs and six pharmaceutical companies.
Koreans are expected to spend more than W100 billion on impotence drugs this year.
(englishnews@chosun.com )
|
